Personalis at World Immunotherapy Congress USA 2019: March 3-5, 2019

Kedar Hastak, PhD
Field Application Scientist
Cancer Genomics & Immuno-Oncology

Tuesday, March 5 | 2:20 PM 

Comprehensive Immunogenomics for Biomarker Discovery from a Single Sample

• While the success of checkpoint blockade has been promising, it’s increasingly
  apparent that predicting patient response to immunotherapies requires a more
  robust approach to tumor immunogenomics.
• By combining highly sensitive, exome-scale DNA and RNA sequencing with
  advanced analytics, ImmunoID NeXT provides a multidimensional view of the
  tumor and the tumor microenvironment (TME) from a single sample
  preparation.
• In this presentation, we’ll discuss the benefits of this unique, innovative design
  for immuno-oncology translational research including mastering challenging
  samples, utilizing optimized algorithms, and obtaining accurate genomic data for
  identifying novel biomarker signatures.